Candel Therapeutics 第四季度运营亏损达1575万美元,远超IBES预估的1390万美元

美股速递
Yesterday

Candel Therapeutics公司最新财报显示,其第四季度运营亏损为1575.2万美元,这一数字显著高于IBES分析师普遍预测的1390万美元亏损。实际业绩与市场预期存在明显差距,反映出公司当期运营表现未达市场共识。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10